Brevan Howard Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.7M Buy
317,233
+65,058
+26% +$10.6M 0.41% 33
2025
Q4
$49.4M Buy
252,175
+244,883
+3,358% +$58.3M 0.54% 31
2025
Q3
$2.05M Sell
7,292
-42,056
-85% -$10.7M 0.01% 549
2025
Q2
$10.8M Buy
+49,348
New +$7.97M 0.06% 174
2024
Q4
Sell
-11,074
Closed -$1.89M 1327
2024
Q3
$1.89M Buy
+11,074
New +$1.6M 0.01% 296
2024
Q1
Sell
-9,157
Closed -$965K 1262
2023
Q4
$965K Buy
+9,157
New +$999K 0.01% 245
2023
Q3
Sell
-48,000
Closed -$5.72M 425
2023
Q2
$5.72M Buy
+48,000
New +$4.96M 0.12% 30

Other funds holding ORCL

Brevan Howard Capital Management's ORCL Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Oracle (ORCL) stake by 26% in Q1 2026, buying an estimated $10.6M and bringing the position to 317,233 shares worth $46.7M. The position accounts for 0.41% of the portfolio, ranked #33.

Brevan Howard Capital Management first reported a position in ORCL in Q2 2023 and has held it in 7 quarters since. The position peaked at $49.4M in Q4 2025. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Brevan Howard Capital Management held 317,233 shares of Oracle worth $46.7M as of Q1 2026.
  • Brevan Howard Capital Management bought 65,058 Oracle shares in Q1 2026, an estimated $10.6M.
  • Oracle made up 0.41% of Brevan Howard Capital Management's portfolio in Q1 2026, its #33 holding.
  • Brevan Howard Capital Management first reported a position in Oracle in Q2 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Oracle position peaked at $49.4M in Q4 2025.
  • 3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.